Last Edition: September 24-25 2020,
Digitally Streamed from Lausanne

Speakers


2020
Ron Alfa
Recursion Pharmaceuticals
2020
Caroline Arber-Barth
Department of oncology UNIL CHUV , Ludwig Institute for Cancer Research Lausanne, University of Lausanne and Lausanne University Hospital
2020
Massimo Bocchi
CellPly Srl
2020
William Burns
Molecular Partners
20192020
Ana Cerdeira
Molecular Partners
2020
Raphael Conz
Economic Promotion Manager at SPEI, Vaud
201820192020
Georges Coukos
Department of oncology UNIL CHUV, Lausanne University Hospital, Ludwig Institute for Cancer Research Lausanne
2020
Michele De Palma
EPFL
2020
Maryellen Giger
The University of Chicago
2020
Brian Hashemi
Salus Partners SA
202020192018
Jens Hasskarl
Celgene a BMS Company
2020
Sahar Hosseinian
Novigenix SA
2020
Lana Kandalaft
Department of oncology UNIL CHUV, Lausanne University Hospital, Ludwig Institute for Cancer Research Lausanne
20182020
Kolleen Kennedy
Varian Medical Systems
2020
Dorothea Ledergerber
Novartis
2020
Anant Madabhushi
Case Western Reserve University
2020
Robert Murphy
Carnegie Mellon University
2020
Nasri Nahas
Biopôle SA
201820192020
Christopher Nicodemus
AIT Strategies (Franconia, NH USA)
2020
Antoine Papiernik
Sofinnova Partners
2020
Freddy Radtke
EPFL
2020
Christina Rångemark Åkerman
Dell Medical School at the University of Texas
2020
Herb Riband
InnAxx Consulting
20192020
Titta Rosvall-Puplett
Bristol Myers Squibb (BMS)
2020
Christian Ruiz
University of Basel
2020
Bettina Ryll
Melanoma Patient Network Europe
2020
Raphaël Stadelmann
Service d’hématologie, CHUV, Lausanne
2020
Giulio Superti Furga
Medical University of Vienna
2020
Li Tang
EPFL
2020
Alexandra Vallon-Eberhard
Roche Diagnostics
2020
Miro Venturi
20192020
Jing Watnick
Vigeo Therapeutics
2020

2019
Antonino Amato
BetaGlue Technologies
2019
Stella Augustus
Seattle Genetics
2019
Eugene Bajorinas
Novian Health
2019
Ayse Baker
Chugai Pharma
2019
William Burns
Molecular Partners
20192020
Ata Tuna Ciftlik
Lunaphore Technologies
2019
Raphael Conz
Economic Promotion Manager at SPEI, Vaud
201820192020
Ebrahim Delpassand
RadioMedix
2019
Julien Dodet
Orano Med
2019
Andrea Dunbar
CSEM
2019
Manuela Eicher
CHUV - UNIL
2019
Xavier Franz
VARIAN
2019
Jan Groen
Novigenix
2019
Brian Hashemi
Salus Partners SA
202020192018
Thomas Hefti
Novocure
2019
Ralf Hoffmann
Philips Research
2019
Andreas Kjaer
University of Copenhagen
2019
Jack Kuipers
ETH Zurich
2019
Herve Lamarque
Incyte
2019
Chris Martin
ADC Therapeutics
20182019
Alexander McEwan
IPSEN
2019
Laura Millichamp
InsideReg Sàrl
2019
Stephan Morgenthaler
EPFL
2019
Rebecca Morton Doherty
C/Can City Cancer Challenge
2019
Nasri Nahas
Biopôle SA
201820192020
Vann Parker
Precision for Medicine
2019
Christophe Patris de Broe Zeilas
Deep Cube
2019
Gitte Pedersen
Genomic Expression
2019
Bastien Rachet
SamanTree Medical
2019
Herb Riband
InnAxx Consulting
20192020
Pedro Romero
Ludwig Cancer Research
2019
Diana Saraceni
Panakes
20182019
Frederic Sottilini
CarThera
2019
Thomas Travis
Advanced Accelerator Applications (AAA)
2019
Wim Van Criekinge
Ghent University
2019
Manon Van Engeland
Maastricht University
2019
Max Van Min
Cergentis
2019
Miro Venturi
20192020
Suzanne Wait
The Health Policy Partnership
2019

2018
Patrick Amstutz
Molecular Partners
2018
Christina Busmalis
IBM Watson Health
2018
Jurgi Camblong
Sophia genetics
2018
Raphael Conz
Economic Promotion Manager at SPEI, Vaud
201820192020
Erik De Heus
SkinVision
2018
Antoine De Weck
Novartis
2018
Nicolas Demierre
Novigenix
2018
Sorin Draghici
Wayne State University
2018
Tania Dussey-Cavassini
Swiss Federal Office of Pubic Health
2018
Brian Hashemi
Salus Partners SA
202020192018
Lana Kandalaft
Department of oncology UNIL CHUV, Lausanne University Hospital, Ludwig Institute for Cancer Research Lausanne
20182020
Catherine Labouchère
Isrec Foundation
2018
Nicolas Mach
MaxiVAX
2018
Chris Martin
ADC Therapeutics
20182019
Olivier Michielin
CHUV
2018
Nasri Nahas
Biopôle SA
201820192020
Vincent Ossipow
NeoMed
2018
Vaclav Potesil
OPTELLUM
2018
Venkat Reddy
Glenmark Pharmaceuticals
2018
Heinrich Röder
Biodesix
2018
Christopher Rudolf
Volv Global SA
2018
Diana Saraceni
Panakes
20182019
Marc Sluijs
DIGITALHEALTH.NETWORK
2018
Cristina Stefan
Roche Diagnostics
2018
Kurt Stoeckli
Glenmark Pharmaceuticals
2018
Hiroaki Tanaka
Debiopharm
2018
Thierry Weber
Vivactis
2018
Karen Zinkewich-Peotti
Ipsen
2018

Keep me posted

Subscribe our contact list to receive updates about the Convergence in Oncology Summit.